What the low impact of Humira biosimilars teaches us about drug prices

from pharmaphorum Podcast · host pharmaphorum

Almost everyone seems to agree that drug prices are too high. But that agreement stops when it comes to the question of why they’re so high, and to the question of how to bring them down. Goodroot CEO Mike Waterbury and Nuwae Health CEO Ralph Pisano discuss how the community of Goodroot companies, including Nuwae, are attacking that issue from different angles.

Episode metadata supplied by the publisher feed · Published Apr 6, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

What the low impact of Humira biosimilars teaches us about drug prices

0:00 39:45

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

5 Ways AARP Is Fighting to Lower Drug Prices

Mar 30, 2026 ·14m

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of pharmaphorum Podcast?

This episode is 39 minutes long.

When was this pharmaphorum Podcast episode published?

This episode was published on April 6, 2023.

Can I download this pharmaphorum Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!